FDA Working On “Modern” Regulatory Approach Through Collaborations

FDA must modernize its regulatory tools under the Critical Path Initiative to keep parity with advances in drug development, FDA Deputy Commissioner for Medical and Scientific Affairs Scott Gottlieb said at the Pharmaceutical Compliance Congress & Best Practices Forum Nov. 7-9